FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/04/032663 [Registered on: 08/04/2021] Trial Registered Prospectively
Last Modified On: 30/03/2021
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Endometrial cancer - factors affecting disease recurrence 
Scientific Title of Study   Analysis of Clinicopathologic factors affecting the recurrence on carcinoma endometrium 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anupama  
Designation  Professor  
Affiliation  Amrita Institute of Medical Sciences 
Address  Dept. of Gynecologic Oncology Amrita Institute of Medical Sciences Kochi, Kerala, India

Ernakulam
KERALA
682040
India 
Phone  8891728600  
Fax    
Email  anupamarajanbabu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anupama  
Designation  Professor  
Affiliation  Amrita Institute of Medical Sciences 
Address  Dept. of Gynecologic Oncology Amrita Institute of Medical Sciences Kochi, Kerala, India

Ernakulam
KERALA
682040
India 
Phone  8891728600  
Fax    
Email  anupamarajanbabu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anupama  
Designation  Professor  
Affiliation  Amrita Institute of Medical Sciences 
Address  Dept. of Gynecologic Oncology Amrita Institute of Medical Sciences Kochi, Kerala, India

Ernakulam
KERALA
682040
India 
Phone  8891728600  
Fax    
Email  anupamarajanbabu@gmail.com  
 
Source of Monetary or Material Support  
Amrita Institute 
 
Primary Sponsor  
Name  Amrita Institute 
Address  Amrita Institute of Medical Sciences , Ernakulam, Kerala 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Anupama R  Amrita Institute of Medical Sciences  Ponekkara P O Ernakulam Kerala
Ernakulam
KERALA 
8891728600

anupamarajanbabu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Amrita Institute   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C541||Malignant neoplasm of endometrium,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Female 
Details  Patients with carcinoma endometrium 
 
ExclusionCriteria 
Details  Uterine sarcoma 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Overall survival at 5 years  Time of last follow up 
 
Secondary Outcome  
Outcome  TimePoints 
Recurrence free survival  Date of recurrence 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/04/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   to be published after completion of the study 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is an analysis of factors affecting recurrence in patients with endometrial cancer. Once the study is completed we will be providing a summary of the findings and publication details  
Close